Preimplantation Genetic Testing Market to reach USD 762.6 million by the year 2026| Natera, Inc. CooperSurgical, Inc. – MENAFN.COM

(MENAFN - America News Hour) Accordingto the current analysis of Reports and Data, the globalPreimplantationgenetic testing marketwas valued at USD 347.7 million in 2018 and is expected toreach USD 762.6 million by the year 2026, at a CAGR of 10.1%. PreimplantationGenetic testing identifies genetic defects in embryos, which are developedthrough Vitro Fertilization (IVF) before pregnancy. Preimplantation geneticdiagnosis (PGD) is made when one or both the hereditary parents have a knownhereditary disorder, and testing is performed on the embryo to determinewhether it carries the same hereditary disorder.It is used is growing dueto; increasing number of cases related to the predominance of genetic,hereditary and chromosomal diseases, rising knowledge amongst the populationabout the avoidance of genetic disorders.

To Get Sample Copy ofReport visit: https://www.reportsanddata.com/sample-enquiry-form/2244

Companies considered and profiled in this market study Natera, Inc.; CooperSurgical, Inc.; F. Hoffmann-La Roche AG; Illumina, Inc.; IGENOMIX; and othersA growing number of people suffering from genetic diseases are expected to increase demand for preimplantation genetic testing procedures to have a healthy child. Due to high pregnancy chances with the preimplantation genetic testing procedure as compared to other fertility treatments, the demand for PGI testing is expected to witness high demand among people seeking IVF treatments. Increasing applications for preimplantation genetic testing for the diagnosis of diseases like cancer and other minor disabilities like deafness is expected to create high growth opportunities for preimplantation genetic testing market stakeholders. Stringent government regulations related to the use of PGD have hindered the market growth of PGD market.

Further key findings from the report suggest

Click here to avail the report at an unbelievable discount rate: https://www.reportsanddata.com/discount-enquiry-form/2244

Forthis report, Reports and Data have segmented the Preimplantation genetictesting market based on test type, type, application, end-use, and region:

Test Type (Revenue, USD Million; 20162026)

Type (Revenue, USD Million; 20162026)

Application (Revenue, USD Million; 20162026)

End Use (Revenue, USD Million; 20162026)

Regional Outlook (Revenue in USD Million; 20162026)

Connect with an expert for customization of Report @ https://www.reportsanddata.com/request-customization-form/2244

AboutReports and Data

Reports and Data is a market researchand consulting company that provides syndicated research reports, customizedresearch reports, and consulting services. Our solutions purely focus on yourpurpose to locate, target and analyze consumer behavior shifts acrossdemographics and industries to help clients make smarter business decisions. Weoffer market intelligence studies ensuring relevant and fact-based researchacross multiple industries including Healthcare, Technology, Chemicals, Power,and Energy. We consistently update our research offerings to ensure that ourclients are aware of the latest trends existent in the market. Reports and Datahas a strong base of experienced analysts from varied areas of expertise.

Contact Us: John WatsonHead of Business DevelopmentDirect Line: +1-212-710-1370 E-mail: Reports and Data | Web: http://www.reportsanddata.com

We are a boutique market intelligence and strategic consulting firm dedicated to having a meaningful impact on businesses across the globe. Our stellar estimation and forecasting models have earned recognition across majority of the business forum.

MENAFN21012020007010068ID1099582346

Read more here:
Preimplantation Genetic Testing Market to reach USD 762.6 million by the year 2026| Natera, Inc. CooperSurgical, Inc. - MENAFN.COM

Related Post

Comments are closed.